The global renal denervation devices market is experiencing significant growth as healthcare providers increasingly explore innovative, minimally invasive treatment options for resistant and uncontrolled hypertension. The market was valued at US$ 654.5 million in 2025 and is projected to reach US$ 4,274.2 million by 2036, expanding at a compound annual growth rate (CAGR) of 18.6% from 2026 to...